Imatinib Mesylate and Bevacizumab After First-Line Chemotherapy and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
This study has been completed.
Sponsor:
University of Washington
Collaborator:
Information provided by:
University of Washington
ClinicalTrials.gov Identifier:
NCT00425646
First received: January 19, 2007
Last updated: May 2, 2013
Last verified: May 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | July 2009 |
| Primary Completion Date: | October 2007 (Final data collection date for primary outcome measure) |